Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Sold by AMF Tjanstepension AB

AMF Tjanstepension AB cut its stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 47.0% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 281,733 shares of the pharmacy operator’s stock after selling 249,990 shares during the period. AMF Tjanstepension AB’s holdings in Walgreens Boots Alliance were worth $2,639,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors also recently bought and sold shares of the stock. PNC Financial Services Group Inc. boosted its stake in Walgreens Boots Alliance by 106.6% in the 4th quarter. PNC Financial Services Group Inc. now owns 703,344 shares of the pharmacy operator’s stock worth $6,562,000 after purchasing an additional 362,913 shares in the last quarter. Banco Santander S.A. acquired a new stake in Walgreens Boots Alliance in the 4th quarter worth approximately $136,000. Candriam S.C.A. boosted its stake in Walgreens Boots Alliance by 7.1% in the 4th quarter. Candriam S.C.A. now owns 109,734 shares of the pharmacy operator’s stock worth $1,024,000 after purchasing an additional 7,247 shares in the last quarter. Lindbrook Capital LLC boosted its stake in Walgreens Boots Alliance by 126.8% in the 4th quarter. Lindbrook Capital LLC now owns 4,978 shares of the pharmacy operator’s stock worth $46,000 after purchasing an additional 2,783 shares in the last quarter. Finally, Raymond James Financial Inc. acquired a new stake in Walgreens Boots Alliance during the 4th quarter valued at approximately $9,685,000. 58.59% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several analysts have commented on WBA shares. Bank of America lifted their price objective on shares of Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an “underperform” rating in a research note on Monday, January 13th. Wolfe Research upgraded shares of Walgreens Boots Alliance to a “hold” rating in a research note on Monday, February 24th. Truist Financial decreased their price objective on shares of Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating for the company in a research note on Friday, January 31st. Evercore ISI lifted their price objective on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the company an “in-line” rating in a research note on Monday, January 13th. Finally, Royal Bank of Canada lifted their price objective on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the company a “sector perform” rating in a research note on Wednesday, January 15th. Four equities research analysts have rated the stock with a sell rating, eight have given a hold rating and two have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $11.54.

Walgreens Boots Alliance Stock Performance

WBA opened at $11.39 on Friday. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.64 and a quick ratio of 0.30. The firm has a fifty day moving average price of $10.64 and a 200 day moving average price of $9.72. Walgreens Boots Alliance, Inc. has a 1 year low of $8.08 and a 1 year high of $22.05. The stock has a market cap of $9.84 billion, a P/E ratio of -1.11, a P/E/G ratio of 1.31 and a beta of 0.62.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings results on Friday, January 10th. The pharmacy operator reported $0.51 EPS for the quarter, topping the consensus estimate of $0.38 by $0.13. The company had revenue of $39.50 billion during the quarter, compared to analyst estimates of $37.40 billion. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The firm’s revenue was up 7.6% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.66 EPS. Equities research analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current year.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.